Sartorius to acquire Novasep's chromatography division

By The Science Advisory Board staff writers

January 6, 2021 -- Sartorius has entered into an agreement through its subgroup Sartorius Stedim Biotech to acquire the chromatography process equipment division of Novasep.

The proposed acquisition will bolster Sartorius' position in downstream bioprocessing and build upon the companies' research and development partnership. Novasep and Sartorius have been working since 2018 on an optimized system for membrane-based low-pressure chromatography that processes larger molecules more productively. A product is expected to be launched soon.

The companies agreed not to disclose the purchase price until necessary regulatory approvals have been obtained. The transaction is expected to close during the first half of 2021.

Sartorius acquires WaterSep BioSeparations
Sartorius Stedim Biotech has acquired WaterSep BioSeparations for approximately $27 million plus an earn-out based on sales revenues through 2023...
Sensorion, Novasep ink gene therapy agreement
Sensorion and Novasep have signed an agreement for the manufacturing of adeno-associated virus vectors covering a gene therapy program that targets OTOF,...
Novasep, Lysogene partner for gene therapy
Novasep and Lysogene announced that the parties have inked an agreement for the development and manufacturing of an adeno-associated viral vector-based...
Sartorius expands small sample filtration to 50mL
The new Sartolab RF 50 vacuum filtration units are available in two versions, one with an asymmetric 0.22 µm PES membrane for sterile filtration...
The Breakthrough World of Bioprocessing
Biomanufacturing instruments and techniques have become influential in everything from generating high yield pharmaceutical precursors, to biofuel conversion...

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter